1. Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial. Issue 7 (26th October 2020) Authors: Staehler, Michael; Stöckle, Michael; Christoph, Daniel C.; Stenzl, Arnulf; Potthoff, Karin; Grimm, Marc‐Oliver; Klein, Dunja; Harde, Johanna; Brüning, Fabian; Goebell, Peter J.; Augustin, Marinela; Roos, Frederik; Benz‐Rüd, Iris; Marschner, Norbert; Grünwald, Viktor Journal: International journal of cancer Issue: Volume 148:Issue 7(2021) Page Start: 1685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial. Issue 4 (18th August 2020) Authors: Staehler, Michael; Panic, Andrej; Goebell, Peter J.; Merling, Marie; Potthoff, Karin; Herrmann, Edwin; de Geeter, Patrick; Vannier, Corinne; Hogrefe, Cathrin; Marschner, Norbert; Grünwald, Viktor Journal: International journal of cancer Issue: Volume 148:Issue 4(2021) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022) Authors: Powles, Thomas; Tomczak, Piotr; Park, Se Hoon; Venugopal, Balaji; Ferguson, Thomas; Symeonides, Stefan N; Hajek, Jaroslav; Gurney, Howard; Chang, Yen-Hwa; Lee, Jae Lyun; Sarwar, Naveed; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Mahave, Mauricio; Haas, Naomi B; Sawrycki, Piotr; Burgents, Jo... Journal: Lancet oncology Issue: Volume 23:Issue 9(2022) Page Start: 1133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC‐Registry. Issue 5 (22nd November 2019) Authors: Staehler, Michael; Goebell, Peter J.; Müller, Lothar; Emde, Till‐Oliver; Wetzel, Natalie; Kruggel, Lisa; Jänicke, Martina; Marschner, Norbert Journal: International journal of cancer Issue: Volume 146:Issue 5(2020) Page Start: 1307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents. Issue 18 (20th June 2021) Authors: Dürr, Pauline; Schlichtig, Katja; Kelz, Carolin; Deutsch, Birgit; Maas, Renke; Eckart, Michael J.; Wilke, Jochen; Wagner, Harald; Wolff, Kerstin; Preuß, Caroline; Brückl, Valeska; Meidenbauer, Norbert; Staerk, Christian; Mayr, Andreas; Fietkau, Rainer; Goebell, Peter J.; Kunath, Frank; Beckmann, ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 18(2021) Page Start: 1983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗